Nominations Open for the Merkin Prize in Biomedical Technology

CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health. Each year, the prize will celebrate a novel technology and recognize up to four key individuals and/or teams who contributed to the […]

Read More

Nominations Open for the Merkin Prize in Biomedical Technology

CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health. Each year, the prize will celebrate a novel technology and recognize up to four key individuals and/or teams who contributed to the […]

Read More

Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record

Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3 revenue reaching $117.5 million, reflecting a year-on-year increase of 28 percent over Q3 2021 revenue of $94.1 million, and a quarter-on-quarter increase of 16.2 percent over Q2 2022 revenue of […]

Read More

Alchip Technologies Q3 Revenue Sets Fiscal Year ’22 Record

Operating Income and Net Income Up Year-on-Year Taipei, Taiwan, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alchip Technologies set a fiscal year 2022 record with Q3 revenue reaching $117.5 million, reflecting a year-on-year increase of 28 percent over Q3 2021 revenue of $94.1 million, and a quarter-on-quarter increase of 16.2 percent over Q2 2022 revenue of […]

Read More

Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics

Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal validates Jeito’s unique investment model of selecting high–quality assets developed by world-leading teams in therapeutic areas with high unmet need Paris, France, November 29th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to […]

Read More

Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics

Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal validates Jeito’s unique investment model of selecting high–quality assets developed by world-leading teams in therapeutic areas with high unmet need Paris, France, November 29th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to […]

Read More

Cloudian Launches On-Premises Object Storage for Snowflake Analytics Workloads

Solution Offers Public Cloud-like Scalability and Ease of Management in Customer Data Centers SAN MATEO, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) — Cloudian® today announced the launch of its HyperStore® on-prem data lake storage in partnership with Snowflake, the Data Cloud company. Cloudian and Snowflake customers will now have access to data stored on HyperStore that […]

Read More

Cloudian Launches On-Premises Object Storage for Snowflake Analytics Workloads

Solution Offers Public Cloud-like Scalability and Ease of Management in Customer Data Centers SAN MATEO, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) — Cloudian® today announced the launch of its HyperStore® on-prem data lake storage in partnership with Snowflake, the Data Cloud company. Cloudian and Snowflake customers will now have access to data stored on HyperStore that […]

Read More